Different
types of tumors show a preference for specific organs and tissues; circulating breast cancer cells, for example, are likely to take root in bones, lungs, and the brain.
Not exact matches
While it has
shown promise for some
types of tumors and become standard
of care for others, researchers are just beginning to explore how different immunotherapy technologies can be applied to brain cancer.
Goji's are reported to have anti-aging properties and
show anti-
tumor activities against various
types of skin cancer cells by inhibiting
tumor growth and inducing apoptosis.
The study published in Cancer Cell
shows that exosomes from
tumor cells
of breast cancer (and other
tumor types such as ovarian and endometrial) are different in size and composition than those
of healthy cells.
They report that the test can detect significant drops in the metabolic activity levels
of all three
types of tumors within 72 hours when exposed to an effective drug whereas
tumors that were resistant to a drug
show no change.
New research led by Li Ding, Ph.D.,
of Washington University School
of Medicine in St. Louis,
shows that current approaches to genome analysis systematically miss detecting a certain
type of complex mutation in cancer patients»
tumors.
Purushotham points out, «The feasibility
of intraoperative CLI as
shown in this study, in combination with the wide applicability
of F -18-FDG across a range
of solid cancers, provides a stepping stone for clinical evaluation
of this technology in other solid cancer
types that also experience incomplete
tumor resection due to close or involved margins.»
In recent years a body
of evidence has accumulated to
show that chronic inflammation can play an important role in the progression
of some
types of tumors from a premalignant state to full - blown disease.
Surprisingly, they found that although the patterns
of gene expression — as
shown by the RNA sequencing — differed between the hepatocellular carcinomas and the liver cancers with biliary phenotype and depended on the histological
type, the overall pattern
of mutations in the cells was actually similar between the
tumors —
of either
type — that had emerged in patients who had had infections with either hepatitis C or B, and were different in patients without such infections.
«New
tumor analysis method identifies high - risk prostate cancer: Cancer cells» genetic pathways
show which patients are likely to develop aggressive
types of the disease.»
Low doses
of aspirin, an anti-platelet drug, have been
shown to reduce the risk
of some
types of gastrointestinal cancers, but the process by which aspirin hampers
tumor growth has been unclear.
Using all the existing data that was available, Andrechek, along with MSU doctoral student Daniel Hollern, analyzed 1,172 mouse mammary
tumor samples from 26 different preclinical models and was able to compile one
of the largest databases to
show which strains
of mice were best suited to study a particular
type of human breast cancer.
It is known that the genes that accumulate the most mutations are linked to the
tumor type, and we found this too, however we
showed that the mutational spectrum
of a
tumor is determined by breed
type,» says Dr. Ingegerd Elvers, a researcher with Professor Kerstin Lindblad - Toh at both Uppsala University and Broad Institute.
«A number
of other
types of tumors have been
shown to be driven by chimeras, but this one is unique — it codes for a kinase, an enzyme that modifies other proteins, that has not been identified in cancers.»
The research, published online May 26 by Nature Immunology,
shows that GATA - 3 is required for the maintenance and function
of CD8 + T - cells, a T - cell
type mediating the immune response to clear pathogens, eradicate
tumors and promote inflammation.
Depending on the
type of tissue, it plays different protective and mechanical roles, but it has also been
shown to be involved in a number
of diseases, including the growth
of cancer
tumors.
Previous in vitro studies conducted by researchers in other countries
showed that this molecule was able to reduce the multiplication and increase the mortality
of cells from melanoma, the most aggressive
type of skin cancer, as well as breast cancer and neuroblastoma, a
tumor that typically affects patients aged 15 or younger.
«Our work outlines the genetic similarities
of the tissue and cells in different
types of tumors and
shows the strong relationships mice can have to other human cancers too.»
Results
of a phase one trial
show that an investigational topical drug, resiquimod gel, causes regression
of both treated and untreated
tumor lesions and may completely remove cancerous cells from both sites in patients with early stage cutaneous T cell lymphoma (CTCL)-- a rare
type of non-Hodgkin lymphoma that affects the skin.
BETs have been fast - tracked into clinical trials and have
shown impressive slowing
of tumor growth in multiple cancer
types.
They also
showed that drugs against a
type of breast
tumor called HER2 positive breast cancer — such as the dual ERBB2 / EGFR inhibitor lapatinib — potentially could benefit more patients than currently receive them, if analysis
of the
tumor proteins is taken into consideration.
A new study
shows coibamide A has potent anti-cancer activity in mice and cell cultures that model brain
tumors and triple negative breast cancer, two
of the most aggressive and difficult - to - treat
types of cancer.
The study further suggests that NSAIDs such as aspirin, ibuprofen and naproxen have a particularly advantageous effect when taken after diagnosis by colorectal, or CRC, patients without
tumor mutation in the KRAS gene (KRAS wild -
type tumors): The study
shows that NSAID use by this group is associated with a survival benefit
of 40 percent.
Dario C. Altieri, M.D., Wistar's President and CEO and lead author
of the study, and colleagues
showed how the activation
of this pathway leads to an unfavorable prognosis for patients with gliomas — a
type of brain
tumor — and how the pathway could be a valuable therapeutic target in cancer.
These findings
show that MAX acts as a
tumor suppressor gene in one
of the more aggressive
types of lung cancer.
«Agents that block the proteins — CDK4 / 6 inhibitors — have received Food and Drug administration approval for some patients with metastatic breast cancer, but they've also
shown promise against others
types of tumors in clinical trials.
An anti-PD-1 antibody developed by Bristol - Myers Squibb generates excitement with results from a phase I trial
showing that, among 236 patients with various
types of cancer, the treatment shrank
tumors in 28 percent
of melanoma patients, 30 percent
of patients with kidney cancer, and 18 percent
of patients with advanced non-small cell lung cancer.
Depending on characteristics such as how many
tumor cells, blood vessel cells, and immune cells are touching each other, the
tumor microenvironment can nearly triple the chance that a common
type of breast cancer (estrogen - receptor positive / HER2 negative) that has reached the lymph nodes will also metastasize, Condeelis and colleagues
showed in a 2014 study
of 3,760 patients.
They
showed that miR - 200 was always present in epithelial (less invasive) and not in mesenchymal (more invasive)
types of tumors.
The authors also
show that mice with
tumors show an increase in the number
of this
type of circulating progenitor cells.
The research also
showed that gene expression patterns
of individual
tumors varied considerably, and could exceed the variation observed between different cancer
types.
The study conducted at SciLifeLab
shows that temozolomide itself not only is cytotoxically active against glioblastoma
tumors but also against other
types of brain
tumors, such as medulloblastoma and metastases from other primary
tumors.
Similar effects
of rapamycin have been
shown in other
tumor types.
This candidate new drug, a first - in - its - class,
shows activity against a broad range
of tumor types in mice and appears safe at this stage.»
The knowledge about how this cancer form arises and develops is still limited but new results from a research team led by Lene Uhrbom, Uppsala University / SciLifeLab,
shows that disease progress and the malignancy are affected by the cell
type from which the
tumor originates as well as the age
of the patient.
Swanton's lab has since followed the work with comprehensive spatial and temporal genetic analyses
of other
tumor types, including colorectal cancer,
showing the ways that faulty DNA replication promotes chromosomal instability in cancer.
For example, new data has
shown that
tumors that are infiltrated by T cells — a
type of white blood cell that plays an important role in immunity — translate to better outcomes in response to immunotherapy.
Findings published in the Journal
of the National Cancer Institute
show that immune cells do not respond the same way to all
tumor types.
Five were picked up on MRI, but didn't
show up on a mammogram, and one
tumor was missed by both
types of tests.
This compound has
shown promise in improving cardiovascular disease, diabetes, digestive disorders, Alzhiemer's disease and delayed cell growth
of certain
types of tumors.
For the first time, the researchers
showed an upregulation
of this
tumor suppression gene as they added more and more
of the blended apple peels to each
of the cancer
types.